OpenAI’s Miles Wang to Launch $2B AI Drug Discovery Startup Amid Industry Shakeup
OpenAI's Miles Wang plans AI drug discovery startup, signaling a shift in pharmaceutical industry practices.
90
Welcome to VTechX Hub
Sign in to bookmark insights, track signals, and get a personalized feed.
Isomorphic Labs Limited is a British multinational artificial intelligence company based in London, England. Isomorphic Labs was founded by Demis Hassabis, who is the CEO. The company was incorporated on February 24, 2021 and announced on November 4, 2021. It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind, of which Hassabis is also founder and CEO.
Isomorphic Labs is a subsidiary of Alphabet Inc..
Demis Hassabis is the CEO of Isomorphic Labs.
Isomorphic Labs was founded in 2021-02-24.
SourceIsomorphic Labs is headquartered in London.
SourceIsomorphic Labs is based in United Kingdom.
SourceOpenAI's Miles Wang plans AI drug discovery startup, signaling a shift in pharmaceutical industry practices.
VTechX HubAsk VTechX Intelligence about Isomorphic Labs
Deep-dive analysis with verified sources